title: Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
authors.forename: Vikram K
authors.initials: VK
authors.lastname: Mahajan
authors.forename: Pshpinder S
authors.initials: PS
authors.lastname: Chauhan
authors.forename: Nand Lal
authors.initials: NL
authors.lastname: Sharma
authors.forename: Anju L
authors.initials: AL
authors.lastname: Sharma
authors.forename: Karaninder S
authors.initials: KS
authors.lastname: Mehta
mesh_terms: D000368:Aged; D004893:Erythema Nodosum / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage*; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D012720:Severity of Illness Index; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D007917:Leprostatic Agents; D013792:Thalidomide